CASH FLOW DISCLOSURES AND NON CASH INVESTING AND FINANCING ACTIVITIES (Tables)

3 Months Ended

Mar. 31, 2023

Supplemental Cash Flow Elements [Abstract]

Schedule of Cash Flow

The following non-cash investing and financing activities occurred during the three months ended March 31, 2023 and 2022:

	2023		2022
Issuance of share based payments	$	6,819	$	—
Accrued payables for capital expenditures placed into service	2,724		914
Adjustment to Record Noncontrolling Interest at Redemption Value	1,390		2,273

Schedule of Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the three months ended March 31, 2023 and 2022:

	2023		2022
Cash and cash equivalents	$	193,574	$	77,447
Escrowed cash	4,557		10,997
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	198,131	$	88,444

Schedule of Restrictions on Cash and Cash Equivalents

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows for the three months ended March 31, 2023 and 2022:

	2023		2022
Cash and cash equivalents	$	193,574	$	77,447
Escrowed cash	4,557		10,997
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$	198,131	$	88,444